Continuation of clozapine treatment: Practice makes perfect

Eromona Whiskey, Til Wykes, Denise Duncan-McConnell, Elke Haworth, Nick Walsh, Sarah Hastilow, Nicholas Walsh

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)

Abstract

Aims and method: The study aimed to identify the predictors of drop-out from clozapine treatment by examining the demographic and clinical characteristics of patients registered on clozapine within a 6-month period in one NHS Trust. Results: During the study period, 54 patients were registered and began clozapine treatment and 31% had discontinued within 6 months. Two people died and the remainder discontinued because of non-compliance or side-effects, including neutropenia. Two factors were predictive: the age of the patient (older patients were more likely to discontinue) and the hospital where the initial registration was made. Clinical implications: Neither ethnicity, previous registration nor the individual prescriber are a bar to successful persistence with clozapine. However, one set of hospitals with a history of evidence-based practice and high clozapine prescribing was more successful in retaining patients on maintenance treatment. Although specific data are needed to identify more subtle contributing factors to continuation, it is clear that there is scope for improving the rate of persistence with clozapine treatment.

Original languageEnglish
Pages (from-to)211-213
Number of pages3
JournalPsychiatric Bulletin
Volume27
Issue number6
Publication statusPublished - 1 Jun 2003

Cite this